References The DREAMS-3 Phase III clinical study of Masdutide, a head-to-head semaglutide trial, achieved its primary endpoint in dual efficacy in reducing blood sugar and weight, 28 Oct 2025, Innovent Biologics, A Study Comparing IBI362 vs Semaglutide in Chinese Adults with Early Type 2 Diabetes and Obesity, ClinicalTrials.gov ID NCT06184568, Ji L, et al, Safety and efficacy of a GLP-1 and glucagon receptor dual agonist mazdutide (IBI362) 9 mg and 10 mg in Chinese adults with overweight or obesity: A randomised, placebo-controlled, multiple-ascending-dose phase 1b trial
Get In Touch When comparing Semaglutide to other weight loss options for men, it stands out for its efficacy, convenience, and non-invasive nature
Despite its therapeutic benefits, scrutiny around Ozempic has intensified due to serious side effects reported by some patients
For people self-managing their semaglutide protocol, particularly those using compounded semaglutide or following their own dosing schedule, these comprehensive panels provide accountability
When Ozempic (semaglutide) was approved by the FDA in 2017, doctors quickly realized that diabetic patients who took the drug also lost weight
Having undergone cholecystectomy is not listed as a contraindication for GLP-1 receptor agonists in the Summary of Product Characteristics (SmPC) approved by the Medicines and Healthcare products Regulatory Agency (MHRA)
